PROXY STATEMENT 1997

Company

Oncotelic Therapeutics, Inc.

Filed

April 29, 1997

Period of Report

December 31, 1996

Accession Number

0000903112-97-000627

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →